Allstate Investment Management’s Exact Sciences EXAS Stock Holding History

Allstate Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$508K	Buy	+10,257	New	+$419K	0.02%	491

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Allstate Investment Management's EXAS Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Exact Sciences (EXAS) in Q4 2022: 10,257 shares worth $508K. The stake represents 0.02% of the portfolio and ranks #491 among its holdings.

550 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

Allstate Investment Management held 10,257 shares of Exact Sciences worth $508K as of Q4 2022.
Exact Sciences was a new Allstate Investment Management position in Q4 2022.
Exact Sciences made up 0.02% of Allstate Investment Management's portfolio in Q4 2022, its #491 holding.
550 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.